| STARTSEITE |
 |
|
| Impressum |
| Datenschutz |
 |
 |
| SPOT ON | |
Oncological drugs in oversized injection vials … cause waste for millions of euros | |
| NEW ON THE MARKET | |
Ticagrelor (BRILIQUE) for permanent treatment after myocardial infarction? | |
| THERAPY FROM A CRITICAL VIEWPOINT | |
Baclofen (LIORESAL, generics) for alcohol dependency? | |
| a-t READER'S QUESTIONS AND COMMENTS | |
Vaccination in the case of TNF-alpha inhibitors during pregnancy | |
| IN BRIEF | |
Ezetimibe now also for cardiovascular prevention? | |
 |
|
| CURRENT ADR NETWORK REPORT | |
Is evolocumab (REPATHA) diabetogenic? | |
| SIDE EFFECTS | |
Fatal infections with idelalisib (ZYDELIG) | |
| e a-t IN THE INTERNET | |
Oncological drugs in oversized injection vials … cause waste for millions of euros | |
|
© arznei-telegramm 3/2016 | ||
 | ||